OUR MISSION
ChemClarity is a 501c3 that prevents chemical related illnesses by increasing “Chemical Literacy” in the medical and real estate communities.
We are grateful to the CDC’s National Institute for Occupational Safety & Health (NIOSH) and the Environmental Protection Agency (EPA) for their sincere interest in supporting private startups like ChemClarity with their expertise & data.
“Chemical Literacy” is:
The knowledge to identify chemicals in products and building materials;
To recognize chemical-related illnesses;
And the knowledge and network to address them.
OUR VISION
There are 1.1 million medical and 1.6 million real estate professionals in the U.S. on the front lines of seeing chemical impacts on human health in buildings, and ideal partners for scientists on how chemicals research can be used.
Patients are rarely diagnosed today.
Each use of ChemClarity’s intuitive diagnostic tool will increase a medical doctor or real estate professional’s chemical literacy to accelerate the recognition of chemical related illnesses and how to address them in patients and chemicals in buildings.
Risk management is ChemClarity’s goal.
We save significant time and expense for medical doctors in diagnosing patients, without sending patients to multiple specialists for a diagnosis outside of their expertise. ChemClarity proactively prevents significant healthcare, renovation, and litigation expenses.
THE CHALLENGE
The increasing number of chemical related illnesses:
According to the World Health Organization, the health impact of chemicals in 2016 was “1.6 million lives and 45 million disability-adjusted life years lost”. In the U.S. from 1997-2008, childhood developmental disabilities increased 17% (1.8 million children). Asbestos related deaths from Mesothelioma Cancer between 1999-2013 were estimated to be over 189,000.
The gap in the number of chemicals developed and the number banned by Federal Regulations:
There are 86,718 chemicals in commercial use today in the U.S. and over 1,200,000 chemicals used since the 1930s. There are 3,689 chemicals typically found outdoors that are prohibited by Federal Statutes (Clean Air, Clean Water, CERCLA and RCRA), with individual chemicals added to the list monthly.
ChemClarity aggregated the chemical databases from the CDC and EPA to aid in decision making about which products would reduce health issues if removed.
The challenge of our generation is understanding which chemicals are of concern, how to find and remove them, and how to test and treat patients.
What differentiates ChemClarity?
Our AI-driven diagnostic assistant combines data from EPA and CDC databases to perform the analysis for non-scientists.
Our diagnostic assistant categorizes chemicals by symptoms/illnesses/body systems and by chemical ingredient/product/product family.
Our goal is to eliminate the sources of chemicals, to remove them quickly from patients & buildings.
ChemClarity helps identify chemicals that cause chronic and acute illnesses.
THE CHEMCLARITY SOLUTION
ChemClarity increases “chemical literacy” in the real estate and medical communities with an intuitive diagnostic tool, enabling them to recognize chemical related illnesses and address them effectively in patients and buildings.
ChemClarity and its Strategic Partners are improving the recognition of symptoms and access to testing for buildings and patients.
ChemClarity provides an AI-driven Diagnostic Assistant to lead non-scientists through a series of questions about their building and health to derive a list of potential chemical causes of health issues.
Community is the leverage that will reduce chemical related illnesses more quickly, so ChemClarity Community is developing a platform that connects clients with toxicologists, medical toxicologists, industrial hygienists and research scientists as resources for testing and more specific recommendations.
“No Astronaut launches for space with their fingers crossed.
That’s not how we deal with risk.
The best antidote for fear is competence.”